QUAIL RUN BEHAVIORAL HEALTH — History
CCN 034031 | 3-year financial timeline | COVID resilience: 38/100
🛡️ Public data only — no PHI permitted on this instance.
$23M
Latest Revenue (FY2022)
-3.2%
Revenue CAGR (3yr)
5.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $24M | $22M | $23M | +4.4% | -3.2% |
| Operating Expenses | $17M | $20M | $21M | +9.0% | +11.1% |
| Operating Margin | 28.0% | 9.2% | 5.2% | -43.5% | -56.9% |
| Net Income | $7M | $2M | $1M | -41.0% | -58.3% |
| Licensed Beds | 102 | 116 | 116 | +0.0% | +6.6% |
| Total Patient Days | 29,444 | 25,251 | 27,539 | +9.1% | -3.3% |
| Medicare Day % | 8% | 7% | 7% | -3.7% | -7.7% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 38/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -6.2% ($24M → $23M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-3.2%
This Hospital
+7.6%
State Avg
Latest Margin
5.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $22M | -6.2% |
| FY2024 (proj) | $21M | -17.6% |
| FY2025 (proj) | $20M | -29.0% |